Advanced Preclinical Evaluation Frameworks for Autologous iPSC Therapies
- Patient-Derived Complexity: Leveraging bespoke evaluation platforms to navigate the biological diversity of patient-specific iPSC sources
- Non-Editing Solutions: Establishing high-fidelity functional assays to ensure therapeutic consistency and IND readiness in non-gene edited products
- Translation Strategy: Data-driven approaches to bridge the gap between laboratory-scale characterization and clinical-grade therapeutic production